- Home
- ASND vs TOL Comparison
ASND vs TOL Comparison
Compare ASND & TOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ASND | TOL |
|---|---|---|
| Founded | 2006 | 1967 |
| Country | Denmark | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.8B | 13.8B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | ASND | TOL |
|---|---|---|
| Price | $213.03 | $136.05 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 15 |
| Target Price | ★ $256.40 | $150.73 |
| AVG Volume (30 Days) | 708.6K | ★ 1.3M |
| Earning Date | 02-11-2026 | 02-17-2026 |
| Dividend Yield | N/A | ★ 0.74% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 13.49 |
| Revenue | $758,592,045.00 | ★ $10,966,723,000.00 |
| Revenue This Year | $98.90 | N/A |
| Revenue Next Year | $83.74 | $7.92 |
| P/E Ratio | ★ N/A | $10.05 |
| Revenue Growth | ★ 97.46 | 1.11 |
| 52 Week Low | $118.03 | $86.67 |
| 52 Week High | $229.94 | $149.79 |
Technical Indicators
Market Signals| Indicator | ASND | TOL |
|---|---|---|
| Relative Strength Index (RSI) | 54.24 | 46.67 |
| Support Level | $207.28 | $133.87 |
| Resistance Level | $215.98 | $140.24 |
| Average True Range (ATR) | 7.22 | 2.97 |
| MACD | 0.49 | -0.59 |
| Stochastic Oscillator | 62.98 | 22.45 |
Price Performance
Historical ComparisonAbout ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.
About TOL Toll Brothers Inc.
Toll Brothers is the leading luxury homebuilder in the United States with an average sale price well above public competitors'. The company operates in over 60 markets across 24 states and caters to move-up, active-adult, and second-homebuyers. Traditional homebuilding operations represent most of company's revenue. Toll Brothers also builds luxury for-sale and for-rent properties in urban centers across the US. It has its headquarters in Horsham, Pennsylvania.